Combination of t(4;14), del(17p13), del(1p32) and 1q21 gain FISH probes identifies clonal heterogeneity and enhances the detection of adverse cytogenetic profiles in 233 newly diagnosed multiple myeloma

被引：0
|
作者：
Thomas Smol
Annika Dufour
Sabine Tricot
Mathieu Wemeau
Laure Stalnikiewicz
Franck Bernardi
Christine Terré
Benoît Ducourneau
Hervé Bisiau
Agnès Daudignon
机构：
[1] Service d’Hématologie-Immunologie-Cytogénétique,
[2] CH Valenciennes,undefined
[3] Université de Lille Nord de France,undefined
[4] Laboratoire de Cytogénétique Hématologique,undefined
[5] CH Versailles,undefined
[6] Service d’Hématologie Clinique,undefined
[7] CH Valenciennes,undefined
[8] Service d’Hématologie Clinique,undefined
[9] CH Arras,undefined
[10] Service d’Hématologie Clinique,undefined
[11] CH Lens,undefined
[12] Laboratoire de Biologie,undefined
[13] CH Douai,undefined
[14] Institut de génétique médicale,undefined
[15] Hôpital Jeanne de Flandre,undefined
[16] CHRU Lille,undefined
来源：
Molecular Cytogenetics | / 10卷
关键词：
Multiple Myeloma; Interphase FISH; 1q21 gain; 1p32 deletion; Thresholds;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 18 条
  • [1] COMBINATION OF T(4;14), DEL(17P13), DEL(1P32) AND 1Q21 GAIN FISH PROBES IDENTIFIES CLONAL HETEROGENEITY AND ENHANCES DETECTION OF ADVERSE CYTOGENETIC PROFILES IN 233 NEWLY DIAGNOSED MULTIPLE MYELOMA
    Smol, T.
    Dufour, A.
    Tricot, S.
    Wemeau, M.
    Stalnikiewicz, L.
    Bernardi, F.
    Christine, T.
    Daudignon, A.
    HAEMATOLOGICA, 2016, 101 : 514 - 514
  • [2] Combination of t(4;14), del(17p13), del(1p32) and 1q21 gain FISH probes identifies clonal heterogeneity and enhances the detection of adverse cytogenetic profiles in 233 newly diagnosed multiple myeloma
    Smol, Thomas
    Dufour, Annika
    Tricot, Sabine
    Wemeau, Mathieu
    Stalnikiewicz, Laure
    Bernardi, Franck
    Terre, Christine
    Ducourneau, Benoit
    Bisiau, Herve
    Daudignon, Agnes
    MOLECULAR CYTOGENETICS, 2017, 10
  • [3] Synthetic lethality in multiple myeloma harboring double oncogenic hits of 17p13(del) and 1q21(amp)
    Teoh, Phaik Ju
    Chung, Tae-Hoon
    An, Omer
    Chng, Pamela
    Jeyasekharan, Anand
    Yang, He
    Chng, Wee Joo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E50 - E51
  • [4] Chromosome 1p21 deletion defines a subgroup of multiple myeloma with poor clinical outcomes independent of del(13q), del(p53), t(4;14) or 1q21 amplification
    Chang, Hong
    Qi, Connie
    Jiang, Allan
    Xu, Wei
    Young, Trieu
    Mikhael, Joe
    Trudel, Suzanne
    Chen, Christine
    Reece, Donna
    BLOOD, 2007, 110 (11) : 730A - 730A
  • [5] Clinical implications of 13q14 and 17p13 deletion, t(4;14) and 1q21 amplification in patients with relapsed multiple myeloma treated by Thalidomide or Bortezomib (Velcade)
    Kuglik, P.
    Zaoralova, R.
    Filkova, H.
    Greslikova, H.
    Nemec, P.
    Oltova, A.
    Pour, L.
    Adam, Z.
    Krejci, M.
    Hajek, R.
    CHROMOSOME RESEARCH, 2007, 15 : 185 - 186
  • [6] p53-NEIL1 co-abnormalities induce genomic instability and promote synthetic lethality with Chk1 inhibition in multiple myeloma having concomitant 17p13(del) and 1q21(gain)
    Phaik Ju Teoh
    Omer An
    Tae-Hoon Chung
    Thamil Vaiyapuri
    Anandhkumar Raju
    Michal M. Hoppe
    Sabrina H. M. Toh
    Wilson Wang
    Ming Chun Chan
    Melissa J. Fullwood
    Anand D. Jeyasekharan
    Vinay Tergaonkar
    Leilei Chen
    Henry Yang
    Wee Joo Chng
    Oncogene, 2022, 41 : 2106 - 2121
  • [7] p53-NEIL1 co-abnormalities induce genomic instability and promote synthetic lethality with Chk1 inhibition in multiple myeloma having concomitant 17p13(del) and 1q21(gain)
    Teoh, Phaik Ju
    An, Omer
    Chung, Tae-Hoon
    Vaiyapuri, Thamil
    Raju, Anandhkumar
    Hoppe, Michal M.
    Toh, Sabrina H. M.
    Wang, Wilson
    Chan, Ming Chun
    Fullwood, Melissa J.
    Jeyasekharan, Anand D.
    Tergaonkar, Vinay
    Chen, Leilei
    Yang, Henry
    Chng, Wee Joo
    ONCOGENE, 2022, 41 (14) : 2106 - 2121
  • [8] Conventional Cytogenetics and FISH [del13q, del17p, t(11;14), t(4;14)] Findings and Their Relationship with Other Risk Factors in Multiple Myeloma
    Balcik, Ozlem S.
    Albayrak, Murat
    Dagdas, Simten
    Helvaci, Nafiye
    Yokus, Osman
    Ceran, Funda
    Ozet, Gulsum
    Ergocen, Salih
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2011, 21 (04): : 203 - 209
  • [9] Chromosomal Aberrations+1q21 and del(17p13) Predict Survival in Patients With Recurrent Multiple Myeloma Treated With Lenalidomide and Dexamethasone
    Klein, Ulrike
    Jauch, Anna
    Hielscher, Thomas
    Hillengass, Jens
    Raab, Marc S.
    Seckinger, Anja
    Hose, Dirk
    Ho, Anthony D.
    Goldschmidt, Hartmut
    Neben, Kai
    CANCER, 2011, 117 (10) : 2136 - 2144
  • [10] Adverse effects of double-hit combining ISS-Ⅲ stage and 1q gain or del(17p) on prognosis of patients with newly diagnosed multiple myeloma
    刘雪莲
    China Medical Abstracts(Internal Medicine), 2020, 37 (02) : 108 - 109
12